Atlas Trials

Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis

Clinical trial NCT01659658 · TERMINATED

Trial details

NCT number
NCT01659658
Sponsor
Millennium Pharmaceuticals, Inc.
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Relapsed or Refractory Systemic Light Chain Amyloidosis
Start date
2012-12-26
Primary completion
2022-07-11
Enrollment
177

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.